Ingelise J. Gordon

8.7k total citations
17 papers, 1.1k citations indexed

About

Ingelise J. Gordon is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Ingelise J. Gordon has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Ingelise J. Gordon's work include Influenza Virus Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Hepatitis B Virus Studies (4 papers). Ingelise J. Gordon is often cited by papers focused on Influenza Virus Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Hepatitis B Virus Studies (4 papers). Ingelise J. Gordon collaborates with scholars based in United States and United Kingdom. Ingelise J. Gordon's co-authors include Mary E. Enama, Robert T. Bailer, Barney S. Graham, Richard A. Koup, Gary J. Nabel, John R. Mascola, Mario Roederer, Julie E. Ledgerwood, Martha Nason and Charla Andrews and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Ingelise J. Gordon

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingelise J. Gordon United States 14 610 405 337 235 204 17 1.1k
Matthew D. J. Dicks United Kingdom 17 479 0.8× 259 0.6× 377 1.1× 309 1.3× 214 1.0× 21 1.1k
Phillip L. Gomez United States 13 656 1.1× 358 0.9× 454 1.3× 323 1.4× 136 0.7× 13 1.3k
Edith Jasny Germany 13 536 0.9× 193 0.5× 412 1.2× 406 1.7× 70 0.3× 20 1.1k
Ian Poulton United Kingdom 20 569 0.9× 356 0.9× 552 1.6× 329 1.4× 447 2.2× 32 1.3k
Sally Mossman United States 15 263 0.4× 597 1.5× 448 1.3× 185 0.8× 115 0.6× 20 1.0k
Michel Janssens Belgium 16 284 0.5× 364 0.9× 463 1.4× 234 1.0× 146 0.7× 32 973
Daniele Lapa Italy 19 567 0.9× 436 1.1× 118 0.4× 157 0.7× 96 0.5× 58 1.1k
Annelies W. Mesman United States 15 395 0.6× 452 1.1× 302 0.9× 137 0.6× 47 0.2× 24 873
Mathura P. Ramanathan United States 14 346 0.6× 213 0.5× 316 0.9× 161 0.7× 283 1.4× 20 884
Pavitra Roychoudhury United States 23 973 1.6× 461 1.1× 228 0.7× 481 2.0× 65 0.3× 64 1.7k

Countries citing papers authored by Ingelise J. Gordon

Since Specialization
Citations

This map shows the geographic impact of Ingelise J. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingelise J. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingelise J. Gordon more than expected).

Fields of papers citing papers by Ingelise J. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingelise J. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingelise J. Gordon. The network helps show where Ingelise J. Gordon may publish in the future.

Co-authorship network of co-authors of Ingelise J. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Ingelise J. Gordon. A scholar is included among the top collaborators of Ingelise J. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingelise J. Gordon. Ingelise J. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
DeZure, Adam, Emily E. Coates, Zonghui Hu, et al.. (2017). An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial. npj Vaccines. 2(1). 15–15. 20 indexed citations
2.
Ledgerwood, Julie E., Zonghui Hu, Pamela Costner, et al.. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary Clinical Trials. 44. 112–118. 11 indexed citations
3.
Crank, Michelle C., Ingelise J. Gordon, Galina V. Yamshchikov, et al.. (2015). Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults. PLoS ONE. 10(4). e0123969–e0123969. 20 indexed citations
4.
Enama, Mary E., Julie E. Ledgerwood, Laura Novik, et al.. (2014). Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011). PLoS ONE. 9(3). e91366–e91366. 22 indexed citations
5.
Graham, Barney S., Mary E. Enama, Martha Nason, et al.. (2013). DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial. PLoS ONE. 8(4). e59340–e59340. 60 indexed citations
6.
Ledgerwood, Julie E., Ingelise J. Gordon, Galina V. Yamshchikov, et al.. (2012). Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans. Clinical and Vaccine Immunology. 19(11). 1792–1797. 43 indexed citations
7.
Enama, Mary E., Zonghui Hu, Ingelise J. Gordon, et al.. (2012). Randomization to standard and concise informed consent forms: Development of evidence-based consent practices. Contemporary Clinical Trials. 33(5). 895–902. 31 indexed citations
8.
Ledgerwood, Julie E., Theodore C. Pierson, Niraj M. Desai, et al.. (2011). A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial. The Journal of Infectious Diseases. 203(10). 1396–1404. 115 indexed citations
9.
Ledgerwood, Julie E., Chih‐Jen Wei, Zonghui Hu, et al.. (2011). DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. The Lancet Infectious Diseases. 11(12). 916–924. 149 indexed citations
10.
Martin, Julie E., Mark K. Louder, Ingelise J. Gordon, et al.. (2008). A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine. 26(50). 6338–6343. 197 indexed citations
11.
Martin, Julie E., Theodore C. Pierson, Ingelise J. Gordon, et al.. (2007). A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial. The Journal of Infectious Diseases. 196(12). 1732–1740. 131 indexed citations
12.
Martin, Julie E., Nancy J. Sullivan, Mary E. Enama, et al.. (2006). A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial. Clinical and Vaccine Immunology. 13(11). 1267–1277. 168 indexed citations
13.
Parrino, Janie, Lewis McCurdy, Brenda Larkin, et al.. (2006). Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals. Vaccine. 25(8). 1513–1525. 73 indexed citations
14.
15.
16.
Lashford, L. S., Darren R. Jones, Jane Pritchard, et al.. (1987). Therapeutic application of radiolabeled monoclonal antibody UJ13A in children with disseminated neuroblastoma.. PubMed. 53–7. 25 indexed citations
17.
Cook, Ian A., David Ross, & Ingelise J. Gordon. (1976). Recruitment and plasmapheresis of donors to provide human antitetanus immunoglobulin.. Journal of Clinical Pathology. 29(3). 211–214. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew D. J. Dicks Breakdown of academic impact, for papers by Phillip L. Gomez Breakdown of academic impact, for papers by Edith Jasny Breakdown of academic impact, for papers by Ian Poulton Breakdown of academic impact, for papers by Sally Mossman Breakdown of academic impact, for papers by Michel Janssens Breakdown of academic impact, for papers by Daniele Lapa Breakdown of academic impact, for papers by Annelies W. Mesman Breakdown of academic impact, for papers by Mathura P. Ramanathan Breakdown of academic impact, for papers by Pavitra Roychoudhury
Rankless by CCL
2026